Previous studies have demonstrated that varying the frequency and duration of insulin treatment results in different outcomes in the RANK/RANKL/OPG pathway in STZ-induced animal models mimicking the pathogenesis of T1DM [25,27]. The gene discussed is TNFRSF11B; the disease is type 1 diabetes mellitus.